GO:0006294 nucleotide-excision repair, preincision complex assembly: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006294 describes the assembly of a multiprotein complex on damaged DNA that recognizes damage, unwinds the helix, and positions endonucleases for cleavage before the damaged strand is cut.
• The preincision complex is built sequentially in vivo, with factors such as XPC, TFIIH, XPA, RPA, XPG, and XPF-ERCC1 joining in an ordered manner.
• XPA and RPA interact through two distinct surfaces to organize the preincision complex and ensure proper damage verification and incision.
• Cryo-EM and biochemical studies have revealed the molecular architecture and dynamic rearrangements of the preincision complex, including the roles of TFIIH subunits and XPA.
• Defects in preincision complex assembly cause xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy, and influence cisplatin resistance in cancer.
• The assembly step is regulated by ubiquitin-proteasome system components that control the timely turnover and recruitment of nucleotide excision repair factors.
Description
Nucleotide excision repair (NER) is the major DNA repair pathway that removes bulky DNA lesions, including ultraviolet-induced cyclobutane pyrimidine dimers and platinum-DNA adducts. The preincision complex assembly step, annotated as GO:0006294, is a critical intermediate in NER during which damage recognition, DNA helix unwinding, and endonucleolytic positioning occur before the damaged strand is cleaved. This process ensures that the correct DNA strand is incised and that repair synthesis can proceed accurately. Understanding GO:0006294 is essential for researchers studying genome stability, cancer therapy resistance, and inherited repair-deficiency syndromes. The assembly is not a simple binding event but a highly orchestrated series of protein-DNA and protein-protein interactions that have been resolved by live-cell imaging, biochemical reconstitution, and structural biology.
nucleotide-excision repair, preincision complex assembly At A Glance
| GO ID | GO:0006294 |
|---|---|
| GO term | nucleotide-excision repair, preincision complex assembly |
| Ontology | biological_process |
| Synonym | nucleotide-excision repair, preincision complex formation |
| Major function | Assembly of a multiprotein complex on damaged DNA for damage recognition, helix unwinding, and endonucleolytic cleavage |
| Occurs before | Cleavage of the phosphodiester backbone 3' and 5' of the DNA damage site |
| Key protein factors | XPC, TFIIH, XPA, RPA, XPG, XPF-ERCC1, and associated proteins |
| Cellular context | Global genome NER and transcription-coupled NER |
What Is GO:0006294?
GO:0006294, nucleotide-excision repair, preincision complex assembly, is the biological process in which proteins aggregate, arrange, and bond together on DNA to form the multiprotein complex responsible for damage recognition, DNA helix unwinding, and endonucleolytic cleavage at the site of DNA damage. This assembly occurs before the phosphodiester backbone of the damaged strand is cleaved 3' and 5' of the lesion. The term is synonymous with nucleotide-excision repair, preincision complex formation.
Why Is nucleotide-excision repair, preincision complex assembly Important in Cell Biology?
The preincision complex assembly step determines whether NER proceeds to incision and repair synthesis, making it a central control point for genome maintenance. Defects in this process lead to severe human disorders such as xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy, and also modulate the efficacy of platinum-based chemotherapies. Because the assembly is sequential and dynamic, it offers multiple targets for experimental interrogation and therapeutic intervention.
• Preincision complex assembly is required for removal of UV-induced DNA lesions and other bulky adducts.
• It ensures that endonucleolytic cleavage occurs only after damage verification and proper strand positioning.
• Sequential assembly of NER factors in vivo was demonstrated by live-cell imaging, establishing the ordered recruitment model.
• XPA-RPA interactions organize the preincision complex and are essential for damage verification.
• Structural studies reveal dynamic conformational changes in TFIIH and XPA during assembly.
• Defects in assembly factors cause xeroderma pigmentosum and related repair-deficiency syndromes.
• Cisplatin resistance in cancer cells is influenced by NER preincision complex activity.
• Ubiquitin-proteasome system components regulate the timely assembly and disassembly of the preincision complex.
• The process is a target for understanding transcription-coupled repair and its link to neurodegeneration.
• Preincision complex assembly is a model system for studying ordered multiprotein complex formation on DNA.
What Happens During nucleotide-excision repair, preincision complex assembly?
Damage recognition and initial complex formation
In simple terms: The cell first finds the DNA damage and marks the spot.
In global genome NER, the XPC complex recognizes helical distortions caused by bulky lesions and initiates preincision complex assembly. This recognition step is followed by the recruitment of TFIIH, which is required for DNA unwinding and damage verification. In transcription-coupled NER, stalled RNA polymerase II triggers recruitment of CSA and CSB, which then facilitate assembly of the same core preincision factors.
DNA helix unwinding and damage verification
In simple terms: The DNA double helix is opened up so the damage can be checked.
TFIIH, a multi-subunit complex containing XPB and XPD helicases, unwinds the DNA around the lesion in an ATP-dependent manner. XPA and RPA then bind to the opened DNA, with XPA interacting with RPA through two distinct surfaces to organize the preincision complex and verify the damage. This verification step ensures that incision occurs only at genuine lesions.
Positioning of endonucleases XPG and XPF-ERCC1
In simple terms: Molecular scissors are placed on either side of the damage.
After unwinding and verification, the endonucleases XPG and XPF-ERCC1 are recruited and positioned at the 3' and 5' sides of the damage, respectively. Their correct positioning depends on the prior assembly of XPA, RPA, and TFIIH, and on structural rearrangements within the preincision complex. This step completes the preincision complex before the phosphodiester backbone is cleaved.
Sequential assembly and dynamic rearrangements
In simple terms: The complex is built step by step, not all at once.
Live-cell imaging has shown that NER factors assemble sequentially at damage sites in vivo, with XPC, TFIIH, XPA, RPA, XPG, and XPF-ERCC1 joining in an ordered manner. Cryo-EM and biochemical studies reveal that the preincision complex undergoes dynamic conformational changes, including TFIIH subunit rearrangements, that are essential for its function. This ordered assembly provides multiple checkpoints for regulation and quality control.
Key Genes Involved in GO:0006294 nucleotide-excision repair, preincision complex assembly
The following genes encode proteins that are directly involved in or regulate the assembly of the nucleotide-excision repair preincision complex.
| Gene | Major Role | Research Relevance |
|---|---|---|
| XPC | Damage recognition and initiation of global genome NER | Mutations cause xeroderma pigmentosum; target for studying lesion recognition |
| RAD23B | Stabilizes XPC and assists in damage recognition | Component of XPC complex; relevant to NER initiation |
| CETN2 | Centrin-2, involved in XPC complex function | Accessory factor in global genome NER |
| TFIIH subunits (XPB/ERCC3, XPD/ERCC2, GTF2H1-5) | DNA unwinding and damage verification | Mutations cause XP, Cockayne syndrome, trichothiodystrophy |
| XPA | Damage verification and preincision complex organization | Interacts with RPA; mutations cause XP |
| RPA1, RPA2, RPA3 | Single-stranded DNA binding and organization of preincision complex | Essential for XPA recruitment and incision |
| XPG/ERCC5 | 3' endonuclease | Mutations cause XP and Cockayne syndrome; positioned in preincision complex |
| XPF/ERCC4 | 5' endonuclease (with ERCC1) | Mutations cause XP; required for incision |
| ERCC1 | Partner of XPF; 5' incision | Defects cause repair deficiency; target for cisplatin resistance studies |
| CSA/ERCC8 | Transcription-coupled NER initiation | Mutations cause Cockayne syndrome |
| CSB/ERCC6 | Transcription-coupled NER initiation | Mutations cause Cockayne syndrome |
| CUL4A | Ubiquitin ligase regulating NER factors | Controls timely assembly via ubiquitin-proteasome system |
| DDB1 | Ubiquitin ligase adaptor in NER regulation | Regulates XPC and other factors |
| DDB2 | UV-damaged DNA binding protein | Involved in damage recognition and regulation |
| UBE2A | Ubiquitin-conjugating enzyme | Regulates NER factor turnover |
| PSMD4 | Proteasome subunit | Affects NER factor stability |
| TP53 | Regulates NER gene expression and DNA damage response | Modulates preincision complex assembly indirectly |
How Is nucleotide-excision repair, preincision complex assembly Regulated?
The assembly of the nucleotide-excision repair preincision complex is regulated by the ubiquitin-proteasome system, which controls the timely recruitment, modification, and turnover of NER factors such as XPC, DDB2, and XPA. Ubiquitination and proteasomal degradation guide the ordered assembly and disassembly of the complex, preventing premature or persistent incision. Additionally, post-translational modifications and protein-protein interactions, such as the two-surface interaction between XPA and RPA, provide further layers of regulation. Transcriptional regulation of NER genes by TP53 and other factors also influences the availability of preincision complex components.
nucleotide-excision repair, preincision complex assembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| XPA | Xeroderma pigmentosum | XPA knockout or point-mutation cell lines for UV sensitivity assays |
| XPC | Xeroderma pigmentosum | XPC knockout cells for damage recognition studies |
| ERCC1 | Cisplatin resistance, repair deficiency | ERCC1 knockout or overexpression in cancer cell lines |
| XPG/ERCC5 | Xeroderma pigmentosum, Cockayne syndrome | XPG point-mutation knock-in models |
| CSB/ERCC6 | Cockayne syndrome | CSB knockout or tagged knock-in for transcription-coupled NER |
Xeroderma pigmentosum and related repair-deficiency syndromes
Mutations in genes encoding preincision complex components, including XPA, XPC, XPG, XPF, and TFIIH subunits, cause xeroderma pigmentosum, a disorder characterized by extreme UV sensitivity and increased skin cancer risk. Cockayne syndrome and trichothiodystrophy can also result from defects in transcription-coupled NER factors that participate in preincision complex assembly.
Cancer and cisplatin resistance
NER preincision complex activity determines the repair of cisplatin-DNA adducts, and elevated NER capacity contributes to cisplatin resistance in cancer cells. Targeting preincision complex assembly factors such as XPA or ERCC1 is a strategy to sensitize tumors to platinum-based chemotherapy.
Neurodegeneration and aging
Defective transcription-coupled NER, which shares preincision complex components, leads to neurodegeneration in Cockayne syndrome and is implicated in accelerated aging. The assembly step is critical for resolving transcription-blocking lesions in post-mitotic neurons.
From nucleotide-excision repair, preincision complex assembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of XPA impair preincision complex assembly? | XPA knockout cell line |
| How does a patient-derived XPC mutation affect damage recognition? | XPC point-mutation knock-in |
| Where and when do NER factors assemble in live cells? | Tagged knock-in of XPA or XPG with fluorescent protein |
| Does ERCC1 overexpression confer cisplatin resistance? | ERCC1 overexpression cell line |
| What is the role of ubiquitination in NER factor turnover? | Knockout of CUL4A or DDB1 |
| Can structural rearrangements be captured? | Tagged TFIIH subunits for cryo-EM or crosslinking |
How to Study the nucleotide-excision repair, preincision complex assembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Recruitment kinetics and order of NER factors | Sequential assembly studies |
| In vitro NER assay | Damage recognition, unwinding, and incision | Biochemical dissection of preincision complex |
| Cryo-EM | 3D structure and conformational changes | Architecture of preincision complex |
| Crosslinking-mass spectrometry | Protein-protein contact sites | Mapping XPA-RPA and TFIIH interactions |
| Ubiquitin proteomics | Ubiquitination sites and dynamics | Regulation by ubiquitin-proteasome system |
| RNA-seq | Expression of NER genes | Transcriptional regulation in disease models |
| CRISPR knockout screening | Gene dependency for NER function | Identifying novel preincision complex regulators |
| Immunofluorescence | Nuclear foci formation of NER factors | Assessing assembly in fixed cells |
Live-cell imaging of factor recruitment
Fluorescently tagged NER factors, such as XPA or XPG, can be expressed via knock-in and imaged in living cells to track sequential assembly at damage sites. This method reveals the order and kinetics of preincision complex formation.
Biochemical reconstitution and DNA repair assays
In vitro NER assays using purified proteins or cell extracts measure damage recognition, unwinding, and incision. These assays can be coupled with site-specific DNA substrates to dissect the preincision assembly step.
Structural biology (cryo-EM and crosslinking)
Cryo-electron microscopy and crosslinking-mass spectrometry resolve the architecture and dynamic rearrangements of the preincision complex. These approaches identify contact surfaces between XPA, RPA, TFIIH, and endonucleases.
Proteomics and ubiquitin analysis
Mass spectrometry-based proteomics can map ubiquitination sites and interaction networks of NER factors, revealing how the ubiquitin-proteasome system regulates preincision complex assembly.
How CRISPR Can Be Used to Study GO:0006294 nucleotide-excision repair, preincision complex assembly
Knockout
CRISPR knockout of genes such as XPA, XPC, or ERCC1 creates cell models to test their requirement for preincision complex assembly and NER activity. These models are useful for UV sensitivity and cisplatin resistance assays.
Point Mutation
Introducing patient-derived point mutations in XPA or XPC via CRISPR allows study of specific defects in damage recognition or protein-protein interactions. Such models help dissect the functional impact of individual residues in preincision complex assembly.
Knock-in
Tagged knock-in of NER factors with fluorescent or affinity tags enables live-cell imaging and proteomic analysis of the preincision complex. This approach preserves endogenous regulation and stoichiometry.
Overexpression
Overexpression of ERCC1 or other NER factors can model cisplatin resistance and test whether increased preincision complex activity enhances repair. Overexpression models are also used to study dominant-negative effects.
How EDITGENE Supports nucleotide-excision repair, preincision complex assembly Research
Researchers studying nucleotide-excision repair, preincision complex assembly-related genes often need to determine whether a candidate gene is causally involved in damage recognition, complex assembly, or incision. EDITGENE provides CRISPR-based cell model services to enable such functional studies with high specificity and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for nucleotide-excision repair, preincision complex assembly research.
Frequently Asked Questions About nucleotide-excision repair, preincision complex assembly
What is nucleotide-excision repair, preincision complex assembly?
It is the process of assembling a multiprotein complex on damaged DNA that recognizes damage, unwinds the helix, and positions endonucleases before cleavage.
What genes are involved in nucleotide-excision repair preincision complex assembly?
Key genes include XPC, XPA, RPA1/2/3, TFIIH subunits (XPB, XPD), XPG, XPF, ERCC1, and regulatory factors such as CUL4A and DDB1.
What is GO:0006294?
GO:0006294 is the Gene Ontology term for nucleotide-excision repair, preincision complex assembly, a biological process.
How is the preincision complex assembled?
It is assembled sequentially in vivo, with XPC, TFIIH, XPA, RPA, XPG, and XPF-ERCC1 joining in an ordered manner.
What is the role of XPA in preincision complex assembly?
XPA interacts with RPA through two surfaces to organize the complex and verify damage before incision.
Which diseases are linked to defects in preincision complex assembly?
Xeroderma pigmentosum, Cockayne syndrome, trichothiodystrophy, and cancer therapy resistance are linked to defects in this process.
How does the ubiquitin-proteasome system regulate preincision complex assembly?
It controls the timely recruitment, modification, and turnover of NER factors such as XPC and XPA.
What methods are used to study preincision complex assembly?
Live-cell imaging, in vitro NER assays, cryo-EM, crosslinking-mass spectrometry, and ubiquitin proteomics are commonly used.
Can CRISPR be used to study nucleotide-excision repair preincision complex assembly?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable functional dissection of this process.
Why is preincision complex assembly important for cisplatin resistance?
NER preincision complex activity repairs cisplatin-DNA adducts, and increased activity contributes to resistance.
Conclusion
GO:0006294, nucleotide-excision repair, preincision complex assembly, is a highly orchestrated biological process that ensures accurate removal of bulky DNA lesions. Its sequential assembly, dynamic rearrangements, and regulation by the ubiquitin-proteasome system are critical for genome stability and influence human disease and cancer therapy response. Continued research using CRISPR models and advanced structural and imaging methods will further clarify how this complex is built and how it can be targeted therapeutically.
References
- 1. Rechkunova NI et al.. 2011. Nucleotide excision repair: DNA damage recognition and preincision complex assembly.. Biochemistry (Mosc) 76(1):24-35 PMID: 21568837
- 2. Kim M et al.. 2022. Two interaction surfaces between XPA and RPA organize the preincision complex in nucleotide excision repair.. Proc Natl Acad Sci U S A 119(34):e2207408119 PMID: 35969784
- 3. Yu J et al.. 2024. Molecular architecture and functional dynamics of the pre-incision complex in nucleotide excision repair.. Nat Commun 15(1):8511 PMID: 39353945
- 4. Duan M et al.. 2020. Role of Nucleotide Excision Repair in Cisplatin Resistance.. Int J Mol Sci 21(23) PMID: 33291532
- 5. Chauhan AK et al.. 2021. Timely upstream events regulating nucleotide excision repair by ubiquitin-proteasome system: ubiquitin guides the way.. DNA Repair (Amst) 103:103128 PMID: 33991872
- 6. Zhu Q et al.. 2017. Nucleotide Excision Repair: Finely Tuned Molecular Orchestra of Early Pre-incision Events.. Photochem Photobiol 93(1):166-177 PMID: 27696486
- 7. Rechkunova NI et al.. 2010. Nucleotide excision repair in higher eukaryotes: mechanism of primary damage recognition in global genome repair.. Subcell Biochem 50:251-77 PMID: 20012586
- 8. Volker M et al.. 2001. Sequential assembly of the nucleotide excision repair factors in vivo.. Mol Cell 8(1):213-24 PMID: 11511374
